Auckland, New Zealand, 28 August 2019 - Fisher & Paykel Healthcare Corporation Limited advises that all resolutions put to the company's annual shareholders' meeting held in Auckland today were passed. The seven resolutions were:
Resolution 1: To re-elect Lewis Gradon as a Director.
Resolution 2: To re-elect Donal O'Dwyer as a Director.
Resolution 3: To elect Neville Mitchell as a Director.
Resolution 4: To authorise the Directors to fix the fees and expenses of the Company's auditor.
Resolution 5: To approve the issue of share rights to Lewis Gradon as set out in the Notice of Annual Shareholders' Meeting 2019.
Resolution 6: To approve the issue of options to Lewis Gradon as set out in the Notice of Annual Shareholders' Meeting 2019.
Resolution 7: To revoke the Company's current constitution and adopt an updated constitution.
All resolutions were decided by poll. The details of the total number of votes cast in person or by proxy on the polls were as follows:
Resolution
Votes For
%
Votes Against
Total Votes Cast
Abstain
Resolution 1 Re-election of
Lewis Gradon
366,211,794
99.99
34,786
366,506,224
259,644
Resolution 2: Re-election of Donal O'Dwyer
362,028,570
98.84
4,255,366
366,506,224
222,288
Resolution 3: Election Neville Mitchell
366,310,274
99.99
27,823
366,506,224
168,127
Resolution 4: Authorise Directors to fix fees and expenses of auditor
366,032,085
99.92
304,778
366,506,224
169,361
Resolution 5: Issue of share rights to Lewis Gradon
340,475,664
93.13
25,123,366
365,902,722
303,692
Resolution 6: Issue of options to Lewis Gradon
338,904,512
92.70
26,669,393
365,902,722
328,817
Resolution 7: Revoke constitution and adopt updated constitution
366,139,655
99.98
72,793
366,506,224
293,776
Contact: Marcus Driller, VP - Corporate and Company Secretary on +64 9 574 0110. For more information about the company visit our website www.fphcare.com
Attachments
Original document
Permalink
Disclaimer
Fisher & Paykel Healthcare Corporation Ltd. published this content on 30 August 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 August 2019 04:05:11 UTC
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Companyâs products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India and others.